Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Horst Bierau
Observed names:
H Bierau,
H. Bierau
Institutions:
Merck KGaA, Darmstadt (Germany),
Merck Serono S.p.A. (Italy)
Observed institutions:
Merck KGaA, Darmstadt (Germany),
Merck Healthcare KGaA, Darmstadt (Germany),
Fujirebio (Belgium),
University of Birmingham,
Merck Serono S.p.A. (Italy),
KU Leuven
show all 6
ORCID:
0000-0001-8719-6138
Observed ORCID:
0000-0001-8719-6138
OpenAlex ID:
A5078462563
Degradation of an Fc‐fusion recombinant protein by host cell proteases: Identification of a CHO cathepsin D protease
2009
·
Flavie Robert
, Horst Bierau
, et al.
·
Biotechnology and Bioengineering
·
141
Glycoengineered antibodies: towards the next-generation of immunotherapeutics
2018
·
Renato Mastrangeli
, Wolf Palinsky
, et al.
·
Glycobiology
·
84
The Formidable Challenge of Controlling High Mannose-Type N-Glycans in Therapeutic mAbs
2020
·
Renato Mastrangeli
, Maria Concetta Audino
, et al.
·
Trends in biotechnology
·
55
A comparison of intensive cell culture bioreactors operating with Hybridomas modified for inhibited apoptotic response.
1998
·
H Bierau
, A Perani
, et al.
·
Journal of Biotechnology
·
54
Direct process integration of cell disruption and fluidised bed adsorption for the recovery of intracellular proteins
1999
·
Horst Bierau
, Zhanren Zhang
, et al.
·
Journal of Chemical Technology & Biotechnology
·
35
Site-specific N- and O-glycosylation analysis of atacicept
2019
·
Kathrin Stavenhagen
, Rabah Gahoual
, et al.
·
mAbs
·
29
Direct process integration of cell disruption and fluidised bed adsorption in the recovery of labile microbial enzymes
2001
·
Horst Bierau
, Roger J. Hinton
, et al.
·
Bioseparation
·
23
Heterogeneity of Commercial Recombinant Human Growth Hormone (r-hGH) Preparations Containing a Thioether Variant
2009
·
Monica Lispi
, Antonio Datola
, et al.
·
Journal of Pharmaceutical Sciences
·
18
Characterisation of a Novel Growth Hormone Variant Comprising a Thioether Link between Cys182 and Cys189
2007
·
Antonio Datola
, Sophie Richert
, et al.
·
ChemMedChem
·
18
Current views on N-glycolylneuraminic acid in therapeutic recombinant proteins
2021
·
Renato Mastrangeli
, Maria Concetta Audino
, et al.
·
Trends in Pharmacological Sciences
·
16
In vitro biological characterization of IFN- -1a major glycoforms
2014
·
R. Mastrangeli
, M. Rossi
, et al.
·
Glycobiology
·
16
Structural characterisation of the hepatitis C envelope glycoprotein E1 ectodomain derived from a mammalian and a yeast expression system
2007
·
Eric Lorent
, Horst Bierau
, et al.
·
Vaccine
·
14
A deamidated interferon-β variant binds to integrin αvβ3
2018
·
Renato Mastrangeli
, Fabio D'amici
, et al.
·
Cytokine
·
8
Innovative Metrics for Reporting and Comparing the Glycan Structural Profile in Biotherapeutics
2023
·
Renato Mastrangeli
, Abhijeet Satwekar
, et al.
·
Molecules
·
7
PDF
Process integration of cell disruption and fluidised bed adsorption of microbial enzymes: application to the retro-design of the purification of L-asparaginase
2001
·
Horst Bierau
·
University of Birmingham Institutional Research Archive (University of Birmingham)
·
6
PDF
Biological Functions of Interferon β-1a Are Enhanced By Deamidation
2016
·
Renato Mastrangeli
, Luisa Iozzino
, et al.
·
Journal of Interferon & Cytokine Research
·
5
How unique is interferon-β within the type I interferon family?
2018
·
Renato Mastrangeli
, Wolf Palinsky
, et al.
·
Cytokine
·
4
Sustainability by design for recombinant protein therapeutics
2025
·
Renato Mastrangeli
, Maria Concetta Audino
, et al.
·
Drug Discovery Today
·
3
Show more works
View as search
Works count:
19
Citation count:
537
H-index:
12
I10-index:
12
Year
Topic
Type